BioGend Therapeutics Market Cap

BioGend Therapeutics has a market cap or net worth of 4.54 billion as of August 15, 2025. Its market cap has decreased by -3.05% in one year.

Market Cap

4.54B

Enterprise Value

4.00B

Revenue

195.02M

Ranking

n/a

PE Ratio

n/a

Stock Price

36.55

Market Cap Chart

Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 4.54B, an increase of 67.33%. That is a compound annual growth rate of 8.71%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	4.54B	8.62%
Dec 31, 2024	4.18B	-11.18%
Dec 29, 2023	4.71B	109.50%
Dec 30, 2022	2.25B	-18.50%
Dec 30, 2021	2.76B	-22.86%
Dec 31, 2020	3.57B	46.27%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	207.84B
PharmaEssentia	167.97B
Bora Pharmaceuticals Co., LTD.	90.60B
Lotus Pharmaceutical	54.57B
Oneness Biotech	32.28B
Polaris Group	27.70B
Center Laboratories	26.60B
Lumosa Therapeutics	25.91B

Market Cap Rankings